Testing the safety and effectiveness of a vaccine that protects people from a certain kind of infection (pneumococcal disease) after adding a preservative to the vaccine
Final Infant Series Report: A Phase 3, Randomized, Open-Label Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Formulated in Multi-Dose Vials Given With Routine Pediatric Vaccinations in Healthy Infants
Category & Conditions: Vaccine-related Conditions
Medicine: PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
ClinicalTrials.gov Identifier (NCT): NCT01964716
Protocol ID: B4671001
PrintDownloadOpen Plain Language Summary Result: Click here